Showing results (1-10 of 94) with videos related to
Sort By:
Pageof 10
Current Hematologic Malignancy Reports|May 14, 2020
Thrombocytosis and Thrombosis: Is There Really a Correlation?Carlos Galvez, Brady L SteinLeukemia & Lymphoma|October 27, 2022
JAK inhibition in myelofibrosis: how to sequence treatment in this new era of multiple optionsBrady L SteinCurrent Hematologic Malignancy Reports|September 9, 2021
Management of Myelofibrosis-Associated Anemia: Focus on Standard Agents and Novel Therapeutics in Phase 3 Clinical TrialsBrady L SteinJournal of the National Comprehensive Cancer Network : JNCCN|December 15, 2018
Do All Patients With Polycythemia Vera or Essential Thrombocythemia Need Cytoreduction?Kamya Sankar, Brady L SteinBlood|November 29, 2019
From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasmsBrady L Stein, Karlyn MartinCurrent Hematologic Malignancy Reports|October 17, 2017
Prognostication and Initiation of Therapy in Polycythemia Vera: Do We Have it Right?Brady L Stein, Srdan VerstovsekLeukemia & Lymphoma|May 16, 2017
Essential thrombocythemia: a review of the clinical features, diagnostic challenges, and treatment modalities in the era of molecular discoverySarah Chuzi, Brady L SteinSeminars in Thrombosis and Hemostasis|December 25, 2012
Thrombotic and bleeding complications in classical myeloproliferative neoplasmsBrandon McMahon, Brady L SteinInternational Journal of Hematology|March 13, 2012
Splenic infarction, warm autoimmune hemolytic anemia and antiphospholipid antibodies in a patient with infectious mononucleosisElizabeth Cull, Brady L SteinHematology. American Society of Hematology. Education Program|December 7, 2019
From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasmsBrady L Stein, Karlyn MartinPageof 10